198 related articles for article (PubMed ID: 26192445)
1. The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice.
Dang MT; Wehrli S; Dang CV; Curran T
PLoS One; 2015; 10(7):e0133633. PubMed ID: 26192445
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
Cohen JR; Resnick DZ; Niewiadomski P; Dong H; Liau LM; Waschek JA
BMC Cancer; 2010 Dec; 10():676. PubMed ID: 21143927
[TBL] [Abstract][Full Text] [Related]
3. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of medulloblastoma.
Wu X; Northcott PA; Croul S; Taylor MD
Chin J Cancer; 2011 Jul; 30(7):442-9. PubMed ID: 21718590
[TBL] [Abstract][Full Text] [Related]
5. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
6. Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth.
Di Magno L; Manzi D; D'Amico D; Coni S; Macone A; Infante P; Di Marcotullio L; De Smaele E; Ferretti E; Screpanti I; Agostinelli E; Gulino A; Canettieri G
Cell Cycle; 2014; 13(21):3404-13. PubMed ID: 25485584
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
8. Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells.
Scheidt T; Alka O; Gonczarowska-Jorge H; Gruber W; Rathje F; Dell'Aica M; Rurik M; Kohlbacher O; Zahedi RP; Aberger F; Huber CG
Cell Commun Signal; 2020 Jun; 18(1):99. PubMed ID: 32576205
[TBL] [Abstract][Full Text] [Related]
9. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
[TBL] [Abstract][Full Text] [Related]
10. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
Yauch RL; Dijkgraaf GJ; Alicke B; Januario T; Ahn CP; Holcomb T; Pujara K; Stinson J; Callahan CA; Tang T; Bazan JF; Kan Z; Seshagiri S; Hann CL; Gould SE; Low JA; Rudin CM; de Sauvage FJ
Science; 2009 Oct; 326(5952):572-4. PubMed ID: 19726788
[TBL] [Abstract][Full Text] [Related]
11. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
12. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Rudin CM; Hann CL; Laterra J; Yauch RL; Callahan CA; Fu L; Holcomb T; Stinson J; Gould SE; Coleman B; LoRusso PM; Von Hoff DD; de Sauvage FJ; Low JA
N Engl J Med; 2009 Sep; 361(12):1173-8. PubMed ID: 19726761
[TBL] [Abstract][Full Text] [Related]
13. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma.
De Smaele E; Di Marcotullio L; Moretti M; Pelloni M; Occhione MA; Infante P; Cucchi D; Greco A; Pietrosanti L; Todorovic J; Coni S; Canettieri G; Ferretti E; Bei R; Maroder M; Screpanti I; Gulino A
Neoplasia; 2011 Apr; 13(4):374-85. PubMed ID: 21472142
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling drives medulloblastoma growth via CDK6.
Raleigh DR; Choksi PK; Krup AL; Mayer W; Santos N; Reiter JF
J Clin Invest; 2018 Jan; 128(1):120-124. PubMed ID: 29202464
[TBL] [Abstract][Full Text] [Related]
16. Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.
Ward RJ; Lee L; Graham K; Satkunendran T; Yoshikawa K; Ling E; Harper L; Austin R; Nieuwenhuis E; Clarke ID; Hui CC; Dirks PB
Cancer Res; 2009 Jun; 69(11):4682-90. PubMed ID: 19487286
[TBL] [Abstract][Full Text] [Related]
17. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma.
Julian E; Dave RK; Robson JP; Hallahan AR; Wainwright BJ
Oncogene; 2010 Jun; 29(24):3465-76. PubMed ID: 20418906
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma.
Hayden Gephart MG; Su YS; Bandara S; Tsai FC; Hong J; Conley N; Rayburn H; Milenkovic L; Meyer T; Scott MP
J Neurooncol; 2013 Nov; 115(2):161-8. PubMed ID: 24026530
[TBL] [Abstract][Full Text] [Related]
19. β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.
Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgård R; Plate KH; Liebner S
Mol Cancer; 2015 Feb; 14(1):17. PubMed ID: 25645196
[TBL] [Abstract][Full Text] [Related]
20. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S
Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
